Literature DB >> 22406679

[Resection of Klatskin tumors].

D Seehofer1, C Kamphues, P Neuhaus.   

Abstract

Curative treatment of Klatskin tumors by radical surgical procedures with surgical preparation distant to the tumor region results in 5-year survival rates of 30-50%. This requires mandatory en bloc liver resection and resection of the extrahepatic bile duct often together with vascular resection. Nevertheless, the ideal safety margin of 0.5-1 cm remote from the macroscopic tumor extensions cannot be achieved in all cases. Based on hilar anatomy the probability of an adequate safety margin is higher using extended right hemihepatectomy together with portal vein resection compared to left hemihepatectomy. However, due to severe atrophy of the left liver lobe solely left-sided hepatectomy is feasible in some patients. In cases of eligibility for both procedures right hemihepatectomy is preferentially used due to the higher oncological radicality if sufficient liver function is present. Postoperative hepatic insufficiency and bile leakage after demanding biliary reconstruction, often with several small orifices, contribute to the postoperative complication rate of this complex surgical disease pattern.

Entities:  

Mesh:

Year:  2012        PMID: 22406679     DOI: 10.1007/s00104-011-2177-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  31 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Incidence and management of biliary leakage after hepaticojejunostomy.

Authors:  Steve M M de Castro; Koert F D Kuhlmann; Olivier R C Busch; Otto M van Delden; Johan S Laméris; Thomas M van Gulik; Hugo Obertop; Dirk J Gouma
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

3.  Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?

Authors:  Masaru Miyazaki; Atsushi Kato; Hiroshi Ito; Fumio Kimura; Hiroaki Shimizu; Masayuki Ohtsuka; Hiroyuki Yoshidome; Hideyuki Yoshitomi; Katsunori Furukawa; Satoshi Nozawa
Journal:  Surgery       Date:  2007-03-23       Impact factor: 3.982

4.  Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.

Authors:  Mai P Hoang; Linda A Murakata; Nora Katabi; Donald E Henson; Jorge Albores-Saavedra
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

5.  Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; Y Shimizu; A Kato; S Nakamura; H Omoto; N Nakajima; F Kimura; T Suwa
Journal:  Surgery       Date:  1998-02       Impact factor: 3.982

6.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

7.  Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.

Authors:  Peter Neuhaus; Armin Thelen; Sven Jonas; Gero Puhl; Timm Denecke; Wilfried Veltzke-Schlieker; Daniel Seehofer
Journal:  Ann Surg Oncol       Date:  2011-10-01       Impact factor: 5.344

8.  Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.

Authors:  Sung Gyu Lee; Gi Won Song; Shin Hwang; Tae Yong Ha; Deok Bog Moon; Dong Hwan Jung; Ki Hun Kim; Chul Soo Ahn; Myung Hwan Kim; Sung Koo Lee; Kyu Bo Sung; Gi Young Ko
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-23       Impact factor: 7.027

9.  Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China.

Authors:  Liu Yubin; Fang Chihua; Jian Zhixiang; Ou Jinrui; Liu Zixian; Zheng Jianghua; Lin Ye; Jin Haosheng; Lu Chaomin
Journal:  Ann Surg Oncol       Date:  2008-06-11       Impact factor: 5.344

10.  Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.

Authors:  Manousos M Konstadoulakis; Sasan Roayaie; Ilias P Gomatos; Daniel Labow; Maria-Isabell Fiel; Charles M Miller; Myron E Schwartz
Journal:  Am J Surg       Date:  2008-05-07       Impact factor: 2.565

View more
  4 in total

Review 1.  The diagnosis and treatment of cholangiocarcinoma.

Authors:  Arndt Vogel; Henning Wege; Karel Caca; Björn Nashan; Ulf Neumann
Journal:  Dtsch Arztebl Int       Date:  2014-10-31       Impact factor: 5.594

Review 2.  [Perihilar cholangiocarcinoma (Klatskin tumor)].

Authors:  G A Stavrou; M Donati; S Faiss; R M Jenner; K J Niehaus; K J Oldhafer
Journal:  Chirurg       Date:  2014-02       Impact factor: 0.955

3.  Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma.

Authors:  Ning Zeng; Haisu Tao; Chihua Fang; Yingfang Fan; Nan Xiang; Jian Yang; Wen Zhu; Jun Liu; Tianpei Guan; Cheng Fang; Fei Xiang
Journal:  World J Surg Oncol       Date:  2016-02-24       Impact factor: 2.754

4.  Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy--Long-Term Outcome of a Phase II Pilot Study.

Authors:  Andrej Wagner; Marcus Wiedmann; Andrea Tannapfel; Christian Mayr; Tobias Kiesslich; Gernot W Wolkersdörfer; Frieder Berr; Johann Hauss; Helmut Witzigmann
Journal:  Int J Mol Sci       Date:  2015-11-06       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.